Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hahn

Showing results (1121-1130 of 1,198) with videos related to

Pageof 120
Sort By:
Clinical Genitourinary Cancer|December 12, 2012
Gemcitabine, Cisplatin, and sunitinib for metastatic urothelial carcinoma and as preoperative therapy for muscle-invasive bladder cancerMatthew D Galsky, Noah M Hahn, Thomas Powles, et al.
Human Pathology|June 29, 2013
Novel markers of squamous differentiation in the urinary bladderWenbin Huang, Sean R Williamson, Qiu Rao, et al.
Frontiers in Immunology|March 5, 2019
Role of Radiation Therapy in Modulation of the Tumor Stroma and MicroenvironmentHari Menon, Rishab Ramapriyan, Taylor R Cushman, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 18, 2012
Radiation dosimetry and biodistribution of the hypoxia tracer (18)F-EF5 in oncologic patientsLilie L Lin, Antti Silvoniemi, James B Stubbs, et al.
JAMA Oncology|August 23, 2019
Clinical Outcomes of the HIV Protease Inhibitor Nelfinavir With Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer: A Phase 1/2 TrialRamesh Rengan, Rosemarie Mick, Daniel A Pryma, et al.
Cell Death and Differentiation|October 17, 2015
BAX inhibitor-1 is a Ca(2+) channel critically important for immune cell function and survivalD Lisak, T Schacht, A Gawlitza, et al.
The Journal of Urology|August 27, 2021
Four versus 3 Cycles of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Implications for Pathological Response and SurvivalHiten D Patel, Sunil H Patel, Enrique Blanco-Martinez, et al.
JAMA Oncology|April 26, 2019
Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases: A Randomized Phase 2 TrialQuynh-Nhu Nguyen, Stephen G Chun, Edward Chow, et al.
Neurogenetics|August 29, 2001
Inter-laboratory comparison of DNA preservation in archival paraffin-embedded human brain tissue from participating centres on four continentsS Kösel, E M Grasbon-Frodl, K Arima, et al.
Cancer|March 28, 2017
7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trialBing Sun, Eric D Brooks, Ritsuko U Komaki, et al.
Pageof 120

Showing results (1121-1130 of 1,198) with videos related to

Sort By:
Pageof 120
Clinical Genitourinary Cancer|December 12, 2012
Gemcitabine, Cisplatin, and sunitinib for metastatic urothelial carcinoma and as preoperative therapy for muscle-invasive bladder cancerMatthew D Galsky, Noah M Hahn, Thomas Powles, et al.
Human Pathology|June 29, 2013
Novel markers of squamous differentiation in the urinary bladderWenbin Huang, Sean R Williamson, Qiu Rao, et al.
Frontiers in Immunology|March 5, 2019
Role of Radiation Therapy in Modulation of the Tumor Stroma and MicroenvironmentHari Menon, Rishab Ramapriyan, Taylor R Cushman, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 18, 2012
Radiation dosimetry and biodistribution of the hypoxia tracer (18)F-EF5 in oncologic patientsLilie L Lin, Antti Silvoniemi, James B Stubbs, et al.
JAMA Oncology|August 23, 2019
Clinical Outcomes of the HIV Protease Inhibitor Nelfinavir With Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer: A Phase 1/2 TrialRamesh Rengan, Rosemarie Mick, Daniel A Pryma, et al.
Cell Death and Differentiation|October 17, 2015
BAX inhibitor-1 is a Ca(2+) channel critically important for immune cell function and survivalD Lisak, T Schacht, A Gawlitza, et al.
The Journal of Urology|August 27, 2021
Four versus 3 Cycles of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Implications for Pathological Response and SurvivalHiten D Patel, Sunil H Patel, Enrique Blanco-Martinez, et al.
JAMA Oncology|April 26, 2019
Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases: A Randomized Phase 2 TrialQuynh-Nhu Nguyen, Stephen G Chun, Edward Chow, et al.
Neurogenetics|August 29, 2001
Inter-laboratory comparison of DNA preservation in archival paraffin-embedded human brain tissue from participating centres on four continentsS Kösel, E M Grasbon-Frodl, K Arima, et al.
Cancer|March 28, 2017
7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trialBing Sun, Eric D Brooks, Ritsuko U Komaki, et al.
Pageof 120